Nu-Med Plus (NUMD) EPS (Diluted) (QoQ) (2016 - 2025)
Nu-Med Plus (NUMD) EPS (Diluted) (QoQ) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.14 Bn | 173.84 Bn | 6.27 Bn |
| 2 | Stryker | 128.35 Bn | 125.47 Bn | 3.81 Bn |
| 3 | Medtronic | 107.95 Bn | 98.73 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.16 Bn | 66.71 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.67 Bn | 44.00 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.17 Bn | 1.98 Bn |
| 7 | Dexcom | 28.45 Bn | 27.33 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.83 Bn | 26.25 Bn | - |
| 9 | Koninklijke Philips | 25.36 Bn | 22.23 Bn | 2.07 Bn |
| 10 | Nu-Med Plus | 1.67 Mn | 1.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -5.45% |
| Sep 30, 2025 | -2.58% |
| Jun 30, 2025 | 41.48% |
| Mar 31, 2025 | -88.85% |
| Dec 31, 2024 | 44.97% |
| Sep 30, 2024 | -8.04% |
| Jun 30, 2024 | 18.65% |
| Mar 31, 2024 | 62.30% |
| Dec 31, 2023 | -243.60% |
| Sep 30, 2023 | 32.54% |
| Jun 30, 2023 | 13.77% |
| Mar 31, 2023 | -165.06% |
| Dec 31, 2022 | 173.20% |
| Sep 30, 2022 | 0.52% |
| Jun 30, 2022 | 2.65% |
| Mar 31, 2022 | 97.48% |
| Dec 31, 2021 | -1,896.62% |
| Sep 30, 2021 | 51.21% |
| Jun 30, 2021 | 53.28% |
| Mar 31, 2021 | 29.73% |